•
Jun 30, 2012

Ironwood Pharmaceuticals Q2 2012 Earnings Report

Total Revenue
$14.6M
Previous year: $11.3M
+29.6%
EPS
-$0.38
Previous year: -$0.18
+111.1%
Gross Profit
$14.6M
Previous year: $11.3M
+29.7%
Cash and Equivalents
$87.1M
Previous year: $48.2M
+80.7%
Free Cash Flow
-$45.5M
Previous year: -$44.1M
+3.1%
Total Assets
$209M
Previous year: $250M
-16.4%

Ironwood Pharmaceuticals

Ironwood Pharmaceuticals